<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03681704</url>
  </required_header>
  <id_info>
    <org_study_id>17401970500-a</org_study_id>
    <nct_id>NCT03681704</nct_id>
  </id_info>
  <brief_title>the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD</brief_title>
  <official_title>Multicenter Clinical Study on the Treatment of Early Stage Diabetic Kidney Disease With Integrated Traditional Chinese and Western Medicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy and Safety of treatment with Traditional Chinese Medicine HuangQi Decoctions in&#xD;
      Patients with early stage of Diabetic Kidney Disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multi-center, randomized, double-blind, placebo-controlled trial. It is&#xD;
      performed in Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai&#xD;
      Jiao Tong University Affiliated Sixth People's Hospital, Putuo Hospital Affiliated to&#xD;
      Shanghai University of Traditional Chinese Medicine, and Shanghai Baoshan District Hospital&#xD;
      of Integrated Traditional Chinese Medicine and Western Medicine, China.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2018</start_date>
  <completion_date type="Anticipated">September 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ACR</measure>
    <time_frame>24 weeks</time_frame>
    <description>the Urinary albumin/ creatinine ratios in stage Ⅲ diabetes kidney disease patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Diabetic Nephropathy Type 2</condition>
  <arm_group>
    <arm_group_label>HuangQi Decoction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HuangQi Decoction 150ml by mouth ,twice a day for 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HuangQi Decoction placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>HuangQi Decoction placebo 150ml by mouth, twice a day for 24 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HuangQi Decoction</intervention_name>
    <description>HuangQi Decoction 150ml twice a day for 24 weeks</description>
    <arm_group_label>HuangQi Decoction</arm_group_label>
    <other_name>Astragalus and other TCMs Decoction</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HuangQi Decoction placebo</intervention_name>
    <description>traditional Chinese medicine placebo mimic HuangQi Decoction 150ml twice a day for 24 weeks</description>
    <arm_group_label>HuangQi Decoction placebo</arm_group_label>
    <other_name>Astragalus Decoction placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Identify the diagnosis of type 2 diabetes;&#xD;
&#xD;
          2. It meets the medical history of diabetic kidney disease, according to the Mogensen&#xD;
             diagnostic staging standard DKD III;&#xD;
&#xD;
          3. Age 18-75 years old, gender ＆ethnicity are not limited;&#xD;
&#xD;
          4. glycated hemoglobin ≤ 10%;&#xD;
&#xD;
          5. Blood pressure is controlled below 130/80mmHg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Combine other ACEI and ARB application indications other than hypertension;&#xD;
&#xD;
          2. Combine severe primary diseases related to heart, brain, liver and hematopoietic&#xD;
             system;&#xD;
&#xD;
          3. Patients who have acute metabolic disorders such as diabetic ketoacidosis occur in the&#xD;
             past month;&#xD;
&#xD;
          4. Patients who HBV serological indicators except HbsAb are positive and persistent liver&#xD;
             function test transaminase abnormalities;&#xD;
&#xD;
          5. Patients with malignant tumors or history of malignant tumors, history of HIV&#xD;
             infection, history of psychosis, acute central nervous system diseases, severe&#xD;
             gastrointestinal diseases, and banned use of immunosuppressive agents;&#xD;
&#xD;
          6. Patients with acute renal failure, combined with urinary tract infection, menstrual&#xD;
             period, intense exercise, cold and other stress states;&#xD;
&#xD;
          7. pregnant or lactating women;&#xD;
&#xD;
          8. Patients who accepted other clinical trial studies on going ;&#xD;
&#xD;
          9. Patients who combined with serious diseases and dysfunctions in other organs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yueyi Deng, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yueyi Deng, PhD</last_name>
    <phone>18917763063</phone>
    <email>dengyueyi@medmail.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ji Li, PhD</last_name>
    <phone>021-64385700</phone>
    <email>lhtcmkyc@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Longhua Hospital, Shanghai University of Traditional Chinese Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen Xiao</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 11, 2018</study_first_submitted>
  <study_first_submitted_qc>September 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2018</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetic Kidney Disease，Traditional Chinese medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

